A placebo-controlled trial of astaxanthin in subjects with nonalcoholic fatty liver disease - Trial UMIN000008524

Name: Clinical Trial UMIN000008524
Creator: Kanazawa University
Keywords: Nonalcoholic fatty liver disease (NAFLD), dietary supplement, clinical trial, Japan

Access comprehensive clinical trial information for UMIN000008524 through Pure Global AI's free database. This phase not specified trial is sponsored by Kanazawa University and is currently Recruiting. The study focuses on Nonalcoholic fatty liver disease (NAFLD).

This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to University Hospital Medical Information Network data, helping medical device and pharmaceutical companies navigate clinical research efficiently.

Free Database

840K+ Trials

UMIN000008524

Recruiting

dietary supplement

Trial Details

University Hospital Medical Information Network • UMIN000008524

DJ Fang

MedTech Regulatory Expert

Need help with 30+ markets registration?

Pricing

A placebo-controlled trial of astaxanthin in subjects with nonalcoholic fatty liver disease

Study Focus

Disease/Condition

Nonalcoholic fatty liver disease (NAFLD)

Study Type

Interventional

Intervention Type

dietary supplement

Sponsor & Location

Primary Sponsor

Kanazawa University

Location

Japan

Timeline & Enrollment

Phase

N/A

Start Date

Mar 01, 2012

End Date

N/A

ICD-10 Classifications

Liver disease, unspecified

Inflammatory liver disease, unspecified

Alcoholic liver disease, unspecified

Alcoholic fatty liver

Toxic liver disease, unspecified

Data Source

Registry

University Hospital Medical Information Network

Trial ID

UMIN000008524

Type

Non-Device Trial